The Oncology Institute Заявленная компания

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 800 teammates in over 65 clinic locations and growing, TOI is changing oncology for the better. читать еще

Эта компания принимает отзывы от проверенных сотрудников СОТРУДНИКИ УЧАСТНИКИ: 80

ИТОГО РЕЙТИНГИ: 2320

СЕО: Daniel Virnich, M.D., MBA

Daniel Virnich, M.D., MBA The Oncology Institute CEO Rating

The Oncology Institute's CEO, Daniel Virnich, M.D., MBA, has 80 employee ratings and a score of 78/100, placing them in the Top 10% of similar size companies on Comparably with 501-1000 сотрудников and Top 15% of other companies in Los Angeles. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at The Oncology Institute rate Daniel Virnich, M.D., MBA higher than females, giving the CEO a score of 83/100.

Last updated months ago.

Where This Score Ranks The Oncology Institute's CEO Rating

TOP
10%
In the Top 10% of 1832 Similar Sized Companies on Comparably
TOP
15%
In the Top 15% of 403 Nearby Companies in Los Angeles
?
Not enough ratings to compare against competitors.

Sep

Oct

Jun

A78 / 100

Jan

The Oncology Institute CEO Daniel Virnich, M.D., MBA Bio

Dr. Daniel Virnich joined The Oncology Institute in 2020. He believes in focusing on clinician and teammate culture as a key to driving great oncology care and the best patient outcomes.

Before joining The Oncology Institute, Dr. Virnich was the President of DaVita Medical Group, Florida. In that role, Dr. Virnich managed a medical group and IPA with over 1,400 teammates and clinicians. Prior to running HCP’s Florida Market, Dr. Virnich was Senior Vice President of Operations for Healthcare Partners in Southern California. Earlier in his career, he was the Chief Medical Officer for Team Health’s Acute Care services division, which employs over 600 physicians.

Dr. Virnich received his BA and MD from the University of Chicago and his MBA from Northwestern University. He completed his residency in Internal Medicine at UCLA and is a Fellow of the American College of Healthcare Executives.

Who Ranks The Oncology Institute's CEO Rating the Highest?

Ethnicity - Caucasian 86/100

Experience - Entry Level 85/100

Gender - Male 83/100

Who Ranks The Oncology Institute's CEO Rating the Lowest?

Ethnicity - Hispanic or Latino 71/100

Department - Customer Success 72/100

Department - Operations 74/100

The Oncology Institute CEO Daniel Virnich, M.D., MBA At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at The Oncology Institute.

The Oncology Institute's CEO is highly regarded by Caucasian employees, employees with Entry Level experience, and Male employees. However, Hispanic or Latino employees, the Customer Success department, and the Operations department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.